2[1]Martino G, Grohovaz F, Brambilla E, et al. Proinflammatory cytokines regulate antigen-independent T-cell activation by two separate calcium- signaling pathways in multiple sclerosis patients [ J]. Ann Neurol, 1998,43: 340
3[2]Shahinian A, Pfeifer K, Lee PK. Differential T cell costimulatory re quirements in CD28 deficient mice[J]. Science, 1993,261:609
4[3]Kuchroo VK, Das MP, Brown JA. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 development pathways: application to autoimmune disease therapy[J]. Cell, 1995,80:707
5[4]Pasquale F, Maria LF, Marina S, et al. Cytokine production and surface maker expression in acute and stable sclerosis: altered IL-12 production and augmented SLAM-expressing lymphocytes in acute multiple sclerosis[J]. J Immunol, 1998,160:1514
6[5]Ozencl V,Kouwenhoven M,Huang YM,et al. Multiple sclerosis:levels of interlukin-10-secreting blood mononuclear cells are low in untreated patients but augmented during intefferon-β-1b treatment[J]. Scand J Immunol, 1999,49: 554
7John HN, Claudia L, Moses R, et al. N Engl J Med,20(~0,343:938.
8Polman CH. BMJ,2000,321:490.
9Neuhaous O, Farina C, Yassouridis A, et al. Proc Nail Acad Sci USA,2000, 97 : 7452.
10Oliver N, Clithia F, Hartmut W, et al. Neurology,2001,56:702.
